OKYO Pharma Ltd SEC filings OKYO
OKYO Pharma Ltd has 311 filings in SEC EDGAR's recent list, going back to Mar 22, 2021. Its latest annual report, Form 20-F, was filed on Jul 20, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Nov 5, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 5, 2026 | Nov 5, 2026 |
| 6-K | Current report (foreign issuer) | Oct 6, 2026 | Oct 6, 2026 |
| 6-K | Current report (foreign issuer) | Sep 29, 2026 | Sep 29, 2026 |
| 6-K | Current report (foreign issuer) | Sep 9, 2026 | Sep 9, 2026 |
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
| 20-F/A | Amended annual report (foreign issuer) | Aug 7, 2026 | Mar 31, 2026 |
| 4/A | Filing | Aug 7, 2026 | Jul 21, 2026 |
| 4/A | Filing | Aug 7, 2026 | Jul 22, 2026 |
| 4/A | Filing | Aug 7, 2026 | Jul 21, 2026 |
| 4/A | Filing | Aug 7, 2026 | Jul 21, 2026 |
| 4/A | Filing | Aug 7, 2026 | Jul 20, 2026 |
| 4/A | Filing | Aug 7, 2026 | Jul 21, 2026 |
| 4/A | Filing | Aug 7, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 29, 2026 | Jul 27, 2026 |
| 3 | Initial insider ownership | Jul 29, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Jul 28, 2026 | Jul 28, 2026 |
| 6-K | Current report (foreign issuer) | Jul 27, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 23, 2026 | Jul 22, 2026 |
| 4 | Insider transaction | Jul 23, 2026 | Jul 21, 2026 |
| 4 | Insider transaction | Jul 23, 2026 | Jul 21, 2026 |
| 4 | Insider transaction | Jul 23, 2026 | Jul 21, 2026 |
| 6-K | Current report (foreign issuer) | Jul 23, 2026 | Jul 23, 2026 |
| 6-K | Current report (foreign issuer) | Jul 23, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 22, 2026 | Jul 21, 2026 |
| 6-K | Current report (foreign issuer) | Jul 22, 2026 | Jul 22, 2026 |
| 6-K | Current report (foreign issuer) | Jul 22, 2026 | Jul 22, 2026 |
| 6-K | Current report (foreign issuer) | Jul 22, 2026 | Jul 22, 2026 |
| 4 | Insider transaction | Jul 21, 2026 | Jul 20, 2026 |
| 6-K | Current report (foreign issuer) | Jul 21, 2026 | Jul 21, 2026 |
| 6-K | Current report (foreign issuer) | Jul 21, 2026 | Jul 21, 2026 |
| 6-K | Current report (foreign issuer) | Jul 20, 2026 | Jul 20, 2026 |
| 20-F | Annual report (foreign issuer) | Jul 20, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Jul 8, 2026 | Jul 8, 2026 |
| 6-K | Current report (foreign issuer) | Jul 7, 2026 | Jul 7, 2026 |
| 3 | Initial insider ownership | Jun 17, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 8, 2026 |
| 3 | Initial insider ownership | Jun 2, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Jun 1, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Jun 1, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | May 22, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | May 22, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | May 19, 2026 | May 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 29, 2026 | Apr 29, 2026 |
| 6-K | Current report (foreign issuer) | Apr 7, 2026 | Apr 7, 2026 |
| 6-K | Current report (foreign issuer) | Mar 19, 2026 | Mar 19, 2026 |
| 6-K | Current report (foreign issuer) | Mar 19, 2026 | Mar 19, 2026 |
| 6-K | Current report (foreign issuer) | Mar 19, 2026 | Mar 19, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Mar 18, 2026 | Mar 18, 2026 |
| 6-K | Current report (foreign issuer) | Mar 12, 2026 | Mar 12, 2026 |
| 6-K | Current report (foreign issuer) | Feb 23, 2026 | Feb 23, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 18, 2026 | — |
| 424B5 | Prospectus supplement | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 13, 2026 | Feb 13, 2026 |
| 6-K | Current report (foreign issuer) | Feb 13, 2026 | Feb 13, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 12, 2026 | Feb 12, 2026 |
| 424B5 | Prospectus supplement | Feb 12, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 11, 2026 | Feb 11, 2026 |
| 6-K | Current report (foreign issuer) | Feb 11, 2026 | Feb 10, 2026 |
| 424B5 | Prospectus supplement | Feb 11, 2026 | — |
| EFFECT | Filing | Feb 10, 2026 | — |
| 6-K | Current report (foreign issuer) | Feb 10, 2026 | Feb 10, 2026 |
| UPLOAD | Letter from the SEC | Feb 6, 2026 | — |
| CORRESP | Letter to the SEC | Feb 6, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 2, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 30, 2026 | Jan 30, 2026 |
| 6-K | Current report (foreign issuer) | Jan 30, 2026 | Jan 30, 2026 |
| 6-K | Current report (foreign issuer) | Jan 28, 2026 | Jan 28, 2026 |
| 6-K | Current report (foreign issuer) | Jan 23, 2026 | Jan 23, 2026 |
| 6-K | Current report (foreign issuer) | Jan 5, 2026 | Jan 5, 2026 |
| 6-K | Current report (foreign issuer) | Dec 19, 2025 | Dec 19, 2025 |
| 6-K | Current report (foreign issuer) | Dec 15, 2025 | Dec 15, 2025 |
| 6-K | Current report (foreign issuer) | Dec 11, 2025 | Dec 11, 2025 |
| 6-K | Current report (foreign issuer) | Dec 3, 2025 | Dec 3, 2025 |
| 6-K | Current report (foreign issuer) | Nov 21, 2025 | Nov 21, 2025 |
| 6-K | Current report (foreign issuer) | Nov 18, 2025 | Nov 18, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 29, 2025 | — |
| 6-K | Current report (foreign issuer) | Oct 29, 2025 | Oct 29, 2025 |
| 6-K | Current report (foreign issuer) | Oct 16, 2025 | Oct 16, 2025 |
| 6-K | Current report (foreign issuer) | Sep 22, 2025 | Sep 22, 2025 |
| 20-F/A | Amended annual report (foreign issuer) | Aug 12, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 5, 2025 | — |
| 20-F | Annual report (foreign issuer) | Jul 18, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Jul 17, 2025 | Jul 17, 2025 |
| 6-K | Current report (foreign issuer) | Jul 16, 2025 | Jul 16, 2025 |
| 6-K | Current report (foreign issuer) | Jun 11, 2025 | Jun 11, 2025 |
| 424B5 | Prospectus supplement | Jun 11, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 27, 2025 | — |
| 6-K | Current report (foreign issuer) | May 19, 2025 | May 19, 2025 |
| 6-K | Current report (foreign issuer) | May 1, 2025 | May 1, 2025 |
| 6-K | Current report (foreign issuer) | Apr 30, 2025 | Apr 30, 2025 |
| 6-K | Current report (foreign issuer) | Mar 31, 2025 | Mar 31, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 18, 2025 | — |
| 6-K | Current report (foreign issuer) | Mar 10, 2025 | Mar 10, 2025 |
| 6-K | Current report (foreign issuer) | Feb 12, 2025 | Feb 12, 2025 |
| 6-K | Current report (foreign issuer) | Jan 31, 2025 | Jan 31, 2025 |
| 6-K | Current report (foreign issuer) | Jan 29, 2025 | Jan 29, 2025 |
| 6-K | Current report (foreign issuer) | Jan 22, 2025 | Jan 22, 2025 |
| 6-K | Current report (foreign issuer) | Nov 26, 2024 | Nov 26, 2024 |
| 6-K | Current report (foreign issuer) | Oct 30, 2024 | Oct 30, 2024 |
| 6-K | Current report (foreign issuer) | Oct 23, 2024 | Oct 23, 2024 |
| 6-K | Current report (foreign issuer) | Oct 16, 2024 | Oct 16, 2024 |
| 6-K | Current report (foreign issuer) | Sep 10, 2024 | Sep 10, 2024 |
| 6-K | Current report (foreign issuer) | Sep 5, 2024 | Sep 5, 2024 |
| 6-K | Current report (foreign issuer) | Aug 27, 2024 | Aug 27, 2024 |
| 6-K | Current report (foreign issuer) | Aug 23, 2024 | Aug 23, 2024 |
| 6-K | Current report (foreign issuer) | Aug 23, 2024 | Aug 23, 2024 |
| 6-K | Current report (foreign issuer) | Aug 21, 2024 | Aug 21, 2024 |
| 6-K | Current report (foreign issuer) | Aug 15, 2024 | Aug 15, 2024 |
| 20-F | Annual report (foreign issuer) | Aug 13, 2024 | Mar 31, 2024 |
| 6-K | Current report (foreign issuer) | Aug 6, 2024 | Aug 6, 2024 |
| NT 20-F | Filing | Jul 31, 2024 | Mar 31, 2024 |
| 6-K | Current report (foreign issuer) | Jul 11, 2024 | Jul 11, 2024 |
| 6-K | Current report (foreign issuer) | Jul 10, 2024 | Jul 10, 2024 |
| 6-K | Current report (foreign issuer) | Jul 10, 2024 | Jul 10, 2024 |
| 6-K | Current report (foreign issuer) | May 8, 2024 | May 8, 2024 |
| 6-K | Current report (foreign issuer) | Apr 30, 2024 | Apr 30, 2024 |
| 6-K | Current report (foreign issuer) | Apr 9, 2024 | Apr 8, 2024 |
| 6-K | Current report (foreign issuer) | Apr 4, 2024 | Apr 4, 2024 |
| 6-K | Current report (foreign issuer) | Apr 2, 2024 | Apr 2, 2024 |
| 6-K | Current report (foreign issuer) | Mar 29, 2024 | Mar 29, 2024 |
| 6-K | Current report (foreign issuer) | Mar 22, 2024 | Mar 22, 2024 |
| 6-K | Current report (foreign issuer) | Mar 21, 2024 | Mar 21, 2024 |
| 6-K | Current report (foreign issuer) | Mar 20, 2024 | Mar 20, 2024 |
| 6-K | Current report (foreign issuer) | Feb 9, 2024 | Feb 9, 2024 |
| 6-K | Current report (foreign issuer) | Jan 31, 2024 | Jan 31, 2024 |
| 6-K | Current report (foreign issuer) | Jan 8, 2024 | Jan 8, 2024 |
| 6-K | Current report (foreign issuer) | Jan 5, 2024 | Jan 5, 2024 |
| 6-K | Current report (foreign issuer) | Dec 21, 2023 | Dec 21, 2023 |
| 424B5 | Prospectus supplement | Dec 20, 2023 | — |
| 6-K | Current report (foreign issuer) | Dec 18, 2023 | Dec 18, 2023 |
| 424B5 | Prospectus supplement | Dec 18, 2023 | — |
| 6-K | Current report (foreign issuer) | Dec 4, 2023 | Dec 4, 2023 |
| 6-K | Current report (foreign issuer) | Nov 29, 2023 | Nov 29, 2023 |
| 6-K | Current report (foreign issuer) | Nov 1, 2023 | Nov 1, 2023 |
| 424B5 | Prospectus supplement | Oct 31, 2023 | — |
| 4 | Insider transaction | Oct 31, 2023 | Oct 23, 2023 |
| 6-K | Current report (foreign issuer) | Oct 31, 2023 | Oct 31, 2023 |
| 6-K | Current report (foreign issuer) | Oct 10, 2023 | Oct 10, 2023 |
| 6-K | Current report (foreign issuer) | Oct 5, 2023 | Oct 5, 2023 |
| 4 | Insider transaction | Sep 28, 2023 | Sep 15, 2023 |
| 6-K | Current report (foreign issuer) | Sep 15, 2023 | Sep 15, 2023 |
| 6-K | Current report (foreign issuer) | Sep 15, 2023 | Sep 15, 2023 |
| 424B5 | Prospectus supplement | Sep 15, 2023 | — |
| 6-K | Current report (foreign issuer) | Sep 14, 2023 | Sep 14, 2023 |
| 6-K | Current report (foreign issuer) | Sep 14, 2023 | Sep 14, 2023 |
| 424B5 | Prospectus supplement | Sep 13, 2023 | — |
| 6-K | Current report (foreign issuer) | Sep 13, 2023 | Sep 13, 2023 |
| 6-K | Current report (foreign issuer) | Sep 8, 2023 | Sep 8, 2023 |
| 6-K | Current report (foreign issuer) | Aug 30, 2023 | Aug 30, 2023 |
| 6-K | Current report (foreign issuer) | Aug 29, 2023 | Aug 29, 2023 |
| 20-F/A | Amended annual report (foreign issuer) | Aug 25, 2023 | Mar 31, 2023 |
| 6-K | Current report (foreign issuer) | Aug 15, 2023 | Aug 15, 2023 |
| 20-F | Annual report (foreign issuer) | Aug 15, 2023 | Mar 31, 2023 |
| NT 20-F | Filing | Jul 31, 2023 | Mar 31, 2023 |
| 6-K | Current report (foreign issuer) | Jul 31, 2023 | Jul 31, 2023 |
| FWP | Free writing prospectus | Jul 28, 2023 | — |
| 6-K | Current report (foreign issuer) | Jul 28, 2023 | Jul 28, 2023 |
| 424B5 | Prospectus supplement | Jul 28, 2023 | — |
| 6-K | Current report (foreign issuer) | Jul 28, 2023 | Jul 28, 2023 |
| 6-K | Current report (foreign issuer) | Jul 28, 2023 | Jul 28, 2023 |
| 6-K | Current report (foreign issuer) | Jul 27, 2023 | Jul 27, 2023 |
| 424B3 | Prospectus | Jun 15, 2023 | — |
| EFFECT | Filing | Jun 14, 2023 | — |
| EFFECT | Filing | Jun 14, 2023 | — |
| CORRESP | Letter to the SEC | Jun 12, 2023 | — |
| CORRESP | Letter to the SEC | Jun 12, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2023 | — |
| F-1/A | Filing | Jun 9, 2023 | — |
| F-1/A | Filing | Jun 8, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 8, 2023 | — |
| 6-K | Current report (foreign issuer) | Jun 6, 2023 | Jun 6, 2023 |
| CORRESP | Letter to the SEC | Jun 2, 2023 | — |
| F-1/A | Filing | Jun 2, 2023 | — |
| 8-A12B/A | Filing | Jun 2, 2023 | — |
| UPLOAD | Letter from the SEC | May 30, 2023 | — |
| 6-K | Current report (foreign issuer) | May 22, 2023 | May 22, 2023 |
| 6-K | Current report (foreign issuer) | May 19, 2023 | May 19, 2023 |
| F-1 | Registration statement (foreign issuer) | May 17, 2023 | — |
| 6-K | Current report (foreign issuer) | May 15, 2023 | May 15, 2023 |
| 6-K | Current report (foreign issuer) | May 11, 2023 | May 11, 2023 |
| 6-K | Current report (foreign issuer) | May 11, 2023 | May 11, 2023 |
| 6-K | Current report (foreign issuer) | May 3, 2023 | May 3, 2023 |
| 6-K | Current report (foreign issuer) | May 3, 2023 | May 3, 2023 |
| 6-K | Current report (foreign issuer) | May 3, 2023 | May 3, 2023 |
| 6-K | Current report (foreign issuer) | May 2, 2023 | May 2, 2023 |
| 6-K | Current report (foreign issuer) | Apr 25, 2023 | Apr 25, 2023 |
| 6-K | Current report (foreign issuer) | Apr 5, 2023 | Apr 5, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- OKYO (Nasdaq)
- Headquarters
- London, United Kingdom
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1849296
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.